About Pipeline Strategy Events Investors News Contact
 
  about advanced cancer therapeutics  
 

Advanced Cancer Therapeutics (ACT) is leading innovation within the biotechnology industry. Founded in January 2007, the company is focused on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. Utilizing its groundbreaking business arrangement with the James Graham Brown Cancer Center and the University of Louisville Research Foundation, ACT will establish exclusive rights to specific novel therapeutics and fast-track these leading edge discoveries to the pharmaceutical industry, and ultimately the patients who need them.

 
recent news

Advanced Cancer Therapeutics has moved to The Nucleus Building at 300 East Market Street, Suite 280, Louisville, KY 40202.

ACT cleared to start Phase I in 1Q 2014 with novel small molecule, PFK158.

ACT completes an additional $5m captial raise to initiate and complete Phase I trial with PFK158 a novel small molecule drug.